Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010. The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015. Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021.
The Company is primarily engaged in providing diagnostic services centres all over India. The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services. The Company owns an extensive network of integrated diagnostics centres across India primarily in non-metro and lower-tier cities and towns, with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country.
The Company started operating 12 centres in Himachal Pradesh via public private partnership (PPP) in 2012. It installed 50 centres in 2017 and expanded operations across 13 states in 2018. Further, it expanded the operations to over 1500 centres across India in 2020.
The Company in August 2021, came up with an Initial Public Offer of 12,741,036 Equity Shares by raising funds from public aggregati ...ng to Rs.1213.33 Crore, comprising a Fresh Issue of 4,215,516 Equity Shares aggregating to Rs 400 Crore and an Offer for Sale of 8,525,520 Equity Shares aggregating to Rs. 813.33 Crore.
The Company operationalized 26 radiology centers, 50 pathology labs, and 556 collection centers in 2022-23. It expanded geographical presence from 660+ centers in FY 2018 to over 2,800 centers in FY 2023. The Teleradiology hub in Pune achieved prestigious accreditation
from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) during the year 2023.
The Company expanded its geographical presence to more than 3600 centres in FY 2024. It expanded into Jharkhand with the launch of two new centres, by establishing over 600 collection centres in 2025.
40 CT scan units have been commissioned in Maharashtra, with MRI and additional CT installations in progress in FY 2025. In FY2025, retail operations were launched across four states and within a short span, the Company's network expanded from 1,600+ to over 2,400
touchpoints. The Company acquired a 23.53% stake in Apulki Healthcare, making the Company an exclusive diagnostic partner with oncology and cardiac care hospitals in 2025.
FAQs on Krsnaa Diagnostics Ltd
1. Can I buy Krsnaa Diagnostics Ltd from PL Capital? ›
Yes, you can invest in Krsnaa Diagnostics Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Krsnaa Diagnostics Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Krsnaa Diagnostics Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Krsnaa Diagnostics Ltd pay dividends? ›
Yes, Krsnaa Diagnostics Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Krsnaa Diagnostics Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.
3. What is the current share price of Krsnaa Diagnostics Ltd ? ›
As of
19-Mar-2026 , 15:52:41 the share price for Krsnaa Diagnostics Ltd. is ₹ 595.1 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Krsnaa Diagnostics Ltd ? ›
The 52-week high and low of Krsnaa Diagnostics Ltd share price is ₹ 579.15 - ₹ 894.4 as of
19-Mar-2026 , 15:52:41 .
